Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.
Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:
(12) Patent Application: | (11) CA 2164113 |
---|---|
(54) English Title: | IN SITU GEL FOR THERAPEUTIC USE |
(54) French Title: | GEL FORME IN SITU POUR USAGE THERAPEUTIQUE |
Status: | Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication |
(51) International Patent Classification (IPC): |
|
---|---|
(72) Inventors : |
|
(73) Owners : |
|
(71) Applicants : |
|
(74) Agent: | SMART & BIGGAR LP |
(74) Associate agent: | |
(45) Issued: | |
(86) PCT Filing Date: | 1994-06-01 |
(87) Open to Public Inspection: | 1994-12-08 |
Examination requested: | 2001-05-22 |
Availability of licence: | N/A |
Dedicated to the Public: | N/A |
(25) Language of filing: | English |
Patent Cooperation Treaty (PCT): | Yes |
---|---|
(86) PCT Filing Number: | PCT/SE1994/000522 |
(87) International Publication Number: | WO 1994027578 |
(85) National Entry: | 1995-11-29 |
(30) Application Priority Data: | ||||||
---|---|---|---|---|---|---|
|
Pharmaceutical drug delivery composition especially for opthalmological use, comprising: a liquid hypotonic solution of at least
one hydrophilic polymer of the type which undergoes liquid-gel phase transition gelling in situ in contact with a physiological solution, and
a pharmaceutically active compound, as well as the use thereof for local administration of drugs.
L'invention concerne une composition d'apport d'un médicament pharmaceutique, et destinée notamment à un usage ophtalmologique, comprenant une solution hypotonique liquide d'au moins un polymère hydrophile du type subissant une gélification par transition de phase liquide-gel in situ au contact d'une solution physiologique, et un composé pharmaceutiquement actif, ainsi que son utilisation pour l'administration locale de médicaments.
Note: Claims are shown in the official language in which they were submitted.
Note: Descriptions are shown in the official language in which they were submitted.
Sorry, the representative drawing for patent document number 2164113 was not found.
2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.
Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.
For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee and Payment History should be consulted.
Description | Date |
---|---|
Inactive: IPC from MCD | 2006-03-12 |
Application Not Reinstated by Deadline | 2005-12-19 |
Inactive: Dead - No reply to s.30(2) Rules requisition | 2005-12-19 |
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice | 2005-06-01 |
Inactive: Abandoned - No reply to s.29 Rules requisition | 2004-12-17 |
Inactive: Abandoned - No reply to s.30(2) Rules requisition | 2004-12-17 |
Inactive: S.30(2) Rules - Examiner requisition | 2004-06-17 |
Inactive: S.29 Rules - Examiner requisition | 2004-06-17 |
Letter Sent | 2001-06-13 |
Inactive: Status info is complete as of Log entry date | 2001-06-13 |
Inactive: Application prosecuted on TS as of Log entry date | 2001-06-13 |
Request for Examination Requirements Determined Compliant | 2001-05-22 |
All Requirements for Examination Determined Compliant | 2001-05-22 |
Application Published (Open to Public Inspection) | 1994-12-08 |
Abandonment Date | Reason | Reinstatement Date |
---|---|---|
2005-06-01 |
The last payment was received on 2004-03-18
Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following
Please refer to the CIPO Patent Fees web page to see all current fee amounts.
Fee Type | Anniversary Year | Due Date | Paid Date |
---|---|---|---|
MF (application, 3rd anniv.) - standard | 03 | 1997-06-02 | 1997-05-26 |
MF (application, 4th anniv.) - standard | 04 | 1998-06-01 | 1998-05-29 |
MF (application, 5th anniv.) - standard | 05 | 1999-06-01 | 1999-05-27 |
MF (application, 6th anniv.) - standard | 06 | 2000-06-01 | 2000-05-26 |
Request for examination - standard | 2001-05-22 | ||
MF (application, 7th anniv.) - standard | 07 | 2001-06-01 | 2001-06-01 |
MF (application, 8th anniv.) - standard | 08 | 2002-06-03 | 2002-03-20 |
MF (application, 9th anniv.) - standard | 09 | 2003-06-02 | 2003-03-20 |
MF (application, 10th anniv.) - standard | 10 | 2004-06-01 | 2004-03-18 |
Note: Records showing the ownership history in alphabetical order.
Current Owners on Record |
---|
PHARMACIA AB |
Past Owners on Record |
---|
JOHAN CARLFORS |
KATARINA EDSMAN |